Ensign Peak Advisors
CTIC

Ensign Peak Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Ensign Peak Advisors’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,326,062
Closed -$5.57M – 1795
2023
Q1 		$5.57M Hold
1,326,062
– – 0.01% 533
2022
Q4 		$7.97M Buy
1,326,062
+619,785
+88% +$3.72M 0.02% 463
2022
Q3 		$4.11M Buy
706,277
+557,186
+374% +$3.24M 0.01% 568
2022
Q2 		$890K Buy
+149,091
New +$890K ﹤0.01% 1177